Significantly increasing biomedical research in various developed and developing countries is expected to drive market growth.
The global mice model market size is expected to reach USD 2.49 Billion by 2028 registering a CAGR of 6.6% over the forecast period, according to a latest report by Reports and Data.
Market revenue growth is driven by key factor such as constantly increasing biomedical research in various developed as well as developing countries in the last few decades. Animal models, especially mice models, typically receive a significant share of research funding. This is a primary driver expected to support growth of the global mice model market.
The use of mice models has increased from last few years, as a result of developments in gene editing technology, which has greatly aided scientists in the research and development of new drugs. These models are used in a wide range of clinical trials, including oncology and immunology. In response to increasing demand for personalized drugs, the scope for genetically modified humanized mice models has expanded.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/3994
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally. Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.
Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth. Factors that could hinder the growth of this market in the future are rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations.
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Reports @ https://www.reportsanddata.com/report-pricing/3994
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
Charles River, Envigo, Taconic Biosciences, Inc., genOway, Janvier Labs, and Hera BioLabs.
Further, the report segments the Mice Model market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Mice Model Market Segmentation:
Mice Type Outlook (Revenue, USD Billion, 2018–2028)
Technology Outlook (Revenue, USD Billion, 2018–2028)
- Embryonic Stem Cell Injection
- Nuclear Transfer
Use Outlook (Revenue, USD Billion, 2018–2028)
Application Outlook (Revenue, USD Billion, 2018–2028)
- Research & Development
- Infectious Disease
- Immunological Diseases
- Cardiovascular Diseases
- Genetic Diseases
- Neurological Diseases
- Production and Quality Control
End Use Outlook (Revenue, USD Billion, 2018–2028)
- Academic and Research Institutes
- Contract Research Organizations (CRO)
Regional Analysis covers:
- North America
- Rest of EU
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3994
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Whole Exome Sequencing Market @ https://www.biospace.com/article/whole-exome-sequencing-market-trend-rising-number-of-r-and-d-activities-in-biopharmaceutical-sector-and-increasing-adoption-of-whole-exome-sequencing-to-identify-genetic-variations-/
Axial Spondylarthritis Market @ https://www.biospace.com/article/rising-numbers-of-research-and-development-activities-of-pharmaceuticals-for-the-symptomatic-treatment-is-expected-to-drive-axial-spondylarthritis-market-revenue-growth-by-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370